These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11499639)

  • 1. Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis.
    Giovannoni G; Miller DH; Losseff NA; Sailer M; Lewellyn-Smith N; Thompson AJ; Thompson EJ
    J Neurol; 2001 Jun; 248(6):487-95. PubMed ID: 11499639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
    Giovannoni G; Lai M; Thorpe J; Kidd D; Chamoun V; Thompson AJ; Miller DH; Feldmann M; Thompson EJ
    Neurology; 1997 Jun; 48(6):1557-65. PubMed ID: 9191766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease.
    McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
    J Neurol; 1999 Feb; 246(2):87-92. PubMed ID: 10195402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
    Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
    Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
    Wipfler P; Heikkinen A; Harrer A; Pilz G; Kunz A; Golaszewski SM; Reuss R; Oschmann P; Kraus J
    J Neurol; 2013 Jan; 260(1):221-7. PubMed ID: 22875099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.
    Khoury SJ; Orav EJ; Guttmann CR; Kikinis R; Jolesz FA; Weiner HL
    Neurology; 1999 Sep; 53(4):758-64. PubMed ID: 10489037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment.
    Trojano M; Avolio C; Ruggieri M; Defazio G; Giuliani F; Paolicelli D; Livrea P
    Mult Scler; 1998 Jun; 4(3):183-7. PubMed ID: 9762671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue is not associated with raised inflammatory markers in multiple sclerosis.
    Giovannoni G; Thompson AJ; Miller DH; Thompson EJ
    Neurology; 2001 Aug; 57(4):676-81. PubMed ID: 11524478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
    Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
    Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
    Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E
    J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse.
    Rieckmann P; Martin S; Weichselbraun I; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Helwig A
    Neurology; 1994 Dec; 44(12):2367-72. PubMed ID: 7527508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.
    Giovannoni G; Thorpe JW; Kidd D; Kendall BE; Moseley IF; Thompson AJ; Keir G; Miller DH; Feldmann M; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):20-6. PubMed ID: 8558145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
    Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
    Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
    Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis.
    Martino G; Consiglio A; Franciotta DM; Corti A; Filippi M; Vandenbroeck K; Sciacca FL; Comi G; Grimaldi LM
    J Neurol Sci; 1997 Nov; 152(1):51-61. PubMed ID: 9395126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis.
    Rejdak K; Petzold A; Stelmasiak Z; Giovannoni G
    Mult Scler; 2008 Jan; 14(1):59-66. PubMed ID: 17893112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.